Pages that link to "Q34604202"

The following pages link to Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes. (Q34604202):

Displaying 50 items.

• First-in-class, first-in-human phase I results of targeted agents: highlights of the 2008 American society of clinical oncology meeting (Q21198874) (← links)
• Transcriptional regulation of the AP-1 and Nrf2 target gene sulfiredoxin (Q24629286) (← links)
• The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration (Q24644214) (← links)
• NRF2, a Key Regulator of Antioxidants with Two Faces towards Cancer (Q26747249) (← links)
• A review on mitochondrial restorative mechanism of antioxidants in Alzheimer's disease and other neurological conditions (Q26781560) (← links)
• The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases (Q26822972) (← links)
• Oxidative stress and nucleic acid oxidation in patients with chronic kidney disease (Q27006908) (← links)
• Changes in Renal Function and Oxidative Status Associated with the Hypotensive Effects of Oleanolic Acid and Related Synthetic Derivatives in Experimental Animals (Q27305609) (← links)
• Topical application of the synthetic triterpenoid RTA 408 activates Nrf2 and induces cytoprotective genes in rat skin (Q28304535) (← links)
• Identification of chromomoric acid C-I as an Nrf2 activator in Chromolaena odorata (Q28306847) (← links)
• NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis (Q28383075) (← links)
• Stress-activated cap'n'collar transcription factors in aging and human disease (Q28384783) (← links)
• Inflammation and coagulation markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA) (Q28387350) (← links)
• NRF2-regulation in brain health and disease: implication of cerebral inflammation (Q28397785) (← links)
• Identification and characterization of PERK activators by phenotypic screening and their effects on NRF2 activation (Q28544428) (← links)
• Synthetic triterpenoids target the Arp2/3 complex and inhibit branched actin polymerization (Q28571683) (← links)
• Nitro-fatty acids and cyclopentenone prostaglandins share strategies to activate the Keap1-Nrf2 system: a study using green fluorescent protein transgenic zebrafish (Q30586026) (← links)
• Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription. (Q33457162) (← links)
• LAS0811: from combinatorial chemistry to activation of antioxidant response element (Q33507900) (← links)
• Dihydro-CDDO-trifluoroethyl amide (dh404), a novel Nrf2 activator, suppresses oxidative stress in cardiomyocytes (Q33520215) (← links)
• Triterpenoids CDDO-methyl ester or CDDO-ethyl amide and rexinoids LG100268 or NRX194204 for prevention and treatment of lung cancer in mice. (Q33636771) (← links)
• The rexinoid LG100268 and the synthetic triterpenoid CDDO-methyl amide are more potent than erlotinib for prevention of mouse lung carcinogenesis (Q33677828) (← links)
• The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease (Q33716356) (← links)
• Nuclear factor kappaB inhibitors alleviate and the proteasome inhibitor PS-341 exacerbates radiation toxicity in zebrafish embryos (Q33757740) (← links)
• Genetic or pharmacologic activation of Nrf2 signaling fails to protect against aflatoxin genotoxicity in hypersensitive GSTA3 knockout mice (Q33779962) (← links)
• The triterpenoid CDDO-Me delays murine acute graft-versus-host disease with the preservation of graft-versus-tumor effects after allogeneic bone marrow transplantation (Q33838404) (← links)
• Complete protection against aflatoxin B(1)-induced liver cancer with a triterpenoid: DNA adduct dosimetry, molecular signature, and genotoxicity threshold. (Q33848142) (← links)
• Deletion of Keap1 in the lung attenuates acute cigarette smoke-induced oxidative stress and inflammation (Q33868529) (← links)
• Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis. (Q33872540) (← links)
• Genetic analysis of hierarchical regulation for Gata1 and NF-E2 p45 gene expression in megakaryopoiesis (Q33876985) (← links)
• The saponins: polar isoprenoids with important and diverse biological activities (Q33902446) (← links)
• Development of Neh2-luciferase reporter and its application for high throughput screening and real-time monitoring of Nrf2 activators (Q33941688) (← links)
• High levels of Nrf2 determine chemoresistance in type II endometrial cancer (Q33959077) (← links)
• Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: biochemical, pharmacological and toxicological implications (Q33970540) (← links)
• Proteomic analysis shows synthetic oleanane triterpenoid binds to mTOR (Q33983503) (← links)
• Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease (Q34043950) (← links)
• NRF2, cancer and calorie restriction (Q34148599) (← links)
• Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity. (Q34214639) (← links)
• Synthetic triterpenoids prolong survival in a transgenic mouse model of pancreatic cancer. (Q34332428) (← links)
• Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties (Q34415403) (← links)
• Seaweed extracts and unsaturated fatty acid constituents from the green alga Ulva lactuca as activators of the cytoprotective Nrf2-ARE pathway (Q34537322) (← links)
• Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARγ, and HO-1 (Q34979691) (← links)
• Targeting NRF2 signaling for cancer chemoprevention (Q35001318) (← links)
• The effect of ex vivo CDDO-Me activation on nuclear factor erythroid 2-related factor 2 pathway in white blood cells from patients with septic shock (Q35067749) (← links)
• Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells (Q35585136) (← links)
• The role of Nrf2 in pathology of pleomorphic adenoma in parotid gland (Q35592145) (← links)
• Prdx4 is a compartment-specific H2O2 sensor that regulates neurogenesis by controlling surface expression of GDE2. (Q35608957) (← links)
• Formation and signaling actions of electrophilic lipids (Q35804051) (← links)
• Bardoxolone Methyl Prevents Fat Deposition and Inflammation in Brown Adipose Tissue and Enhances Sympathetic Activity in Mice Fed a High-Fat Diet (Q35808984) (← links)
• Pharmacological induction of heme oxygenase-1 by a triterpenoid protects neurons against ischemic injury (Q35911185) (← links)